X
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Details:
Through the acquisition, Zuellig will have the access for Cialis (tadalafil), used to treat erectile dysfunction, and Alimta (pemetrexed), for the treatment of pleural mesothelioma and non-small cell lung cancer, from Eli Lilly.
Lead Product(s): Tadalafil
Therapeutic Area: Psychiatry/Psychology Product Name: Cialis
Highest Development Status: ApprovedProduct Type: Small molecule
Recipient: Eli Lilly
Deal Size: Undisclosed Upfront Cash: Undisclosed
Deal Type: Acquisition February 06, 2024
Details:
Luye grants Zuellig exclusive rights to distribute Seroquel (quetiapine fumarate, immediate release) and Seroquel XR (extended release formulation), atypical anti-psychotic medicines with antidepressant properties, for schizophrenia & bipolar disorder, in Malaysia and Brunei.
Lead Product(s): Quetiapine Hemifumarate
Therapeutic Area: Psychiatry/Psychology Product Name: Seroquel
Highest Development Status: ApprovedProduct Type: Small molecule
Recipient: Luye Pharma
Deal Size: Undisclosed Upfront Cash: Undisclosed
Deal Type: Agreement August 02, 2021
Details:
Zuellig Pharma’s division, ZP Therapeutics will supply, mRNA-1273, the COVID-19 Vaccine Moderna in Southeast Asia, Hong Kong, Macau and Taiwan.
Lead Product(s): mRNA-1273
Therapeutic Area: Infections and Infectious Diseases Product Name: mRNA-1273
Highest Development Status: ApprovedProduct Type: Vaccine
Recipient: Moderna Therapeutics
Deal Size: Undisclosed Upfront Cash: Undisclosed
Deal Type: Agreement April 29, 2021
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results] 
Market Place
